Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 36 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
FGF23 | ENSG00000118972 | 0.00 | 0.00 | 0 | 0 |
C2orf40 | ENSG00000119147 | 0.00 | 0.00 | 0 | 0 |
HSDL2 | ENSG00000119471 | 0.00 | 0.21 | 0 | 1 |
CSF3R | ENSG00000119535 | 0.00 | 0.00 | 0 | 0 |
KDSR | ENSG00000119537 | 0.00 | 0.54 | 0 | 4 |
PGF | ENSG00000119630 | 0.00 | 0.22 | 0 | 2 |
MLH3 | ENSG00000119684 | 0.00 | 0.22 | 0 | 2 |
FLVCR2 | ENSG00000119686 | 0.00 | 0.00 | 0 | 0 |
ABCD4 | ENSG00000119688 | 0.00 | 0.50 | 0 | 3 |
TGFB3 | ENSG00000119699 | 0.00 | 0.12 | 0 | 1 |
ALDH6A1 | ENSG00000119711 | 0.00 | 0.22 | 0 | 2 |
GPR75 | ENSG00000119737 | 0.00 | 0.00 | 0 | 0 |
KLHL29 | ENSG00000119771 | 0.00 | 0.00 | 0 | 0 |
FKBP1B | ENSG00000119782 | 0.17 | 0.12 | 1 | 1 |
TECTB | ENSG00000119913 | 0.00 | 0.00 | 0 | 0 |
ELOVL3 | ENSG00000119915 | 0.00 | 0.47 | 0 | 2 |
SMNDC1 | ENSG00000119953 | 0.00 | 0.31 | 0 | 2 |
PRLHR | ENSG00000119973 | 0.00 | 0.12 | 0 | 1 |
CRHR1 | ENSG00000120088 | 0.00 | 0.00 | 0 | 0 |
DUSP1 | ENSG00000120129 | 0.44 | 0.00 | 2 | 0 |
Showing page 36 |
first page | previous page | next page | last page |